SEC Form 4 · accession 0001181431-15-004551
DAVITA INC. · DVA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Laura Mildenberger
Officer — Chief People Ofcr, Kidney Care
Period of report
Mar 10, 2015
Accepted (ET)
Mar 12, 2015 · 7:32 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000927066
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 10, 2015 | M | 2,700 | $43.35 | A | 9,434 | D | |
| Common Stock | Mar 10, 2015 | F | 1,501 | $78.00 | D | 7,933 | D | |
| Common Stock | Mar 10, 2015 | S | 1,199 | $77.75 | D | 6,734 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Appreciation RightsF1 | $43.35 | Mar 10, 2015 | M | 2,700 | D | Apr 13, 2014 | Apr 13, 2016 | Common Stock | 2,700 | 12,300 | D |
Explanation of responses
- F1Stock Appreciation Rights, granted on 4/13/2011, pursuant to the DaVita Inc. 2002 Equity Compensation Plan, (as amended and restated, the "DaVita HealthCare Partners Inc. 2011 Incentive Award Plan," effective June 6, 2011), which vested 50% each on the third and fourth anniversaries of the grant date.